Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediately if any of the following side effects occur while taking hydroxychloroquine: Incidence not known Some side effects of hydroxychloroquine may occur that usually do not need medical attention. Plaquenil hemolytic anemia Chloroquine resistance countries Ocular Surgery News The American Academy of Ophthalmology has published several dosing and screening recommendations for hydroxychloroquine to avoid potential retinal toxicity, yet some patients. Despite Plaquenil dosing recommendations, retinal toxicity remains. Ocular Surgery News U. S. Edition, September 10, 2018. The American Academy of Ophthalmology has published several dosing and. A risk factor for Plaquenil hydroxychloroquine retinotoxicity is a daily dose that exceeds 5.0 mg of drug per kg of body weight. The tool on the right simply calculates this threshold based on a ppatient’s real body weight. It’s important to understand that the daily dose is only one risk factor for plaquenil retinotoxicity. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. These side effects may go away during treatment as your body adjusts to the medicine. Fundus plaquenil Plaquenil Toxicity - Symptoms, Treatment, Risk Factors., Despite Plaquenil dosing recommendations, retinal toxicity remains Plaquenil and stomach problemsPlaquenil and low white blood countTreating ra with plaquenilWhat does plaquenil help A CGS Administrators, LLC Medicare Local Coverage Determination LCD allows coverage of fundus photography L34399 for diagnosis of conditions such as macular degeneration. Fundus photography is usually medically necessary no more than two times per year. Fundus photography of a normal retina will be considered not medically necessary. Fundus Photography - Medical Clinical Policy Bulletins Aetna. Plaquenil Risk Calculators. Plaquenil - FDA prescribing information, side effects and uses. This article is from June 2011 and may contain outdated material. Download PDF. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. Hydroxychloroquine sulfate HCQ, Plaquenil is an analogue of chloroquine CQ, an antimalarial agent, used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune disorders. Its use has been associated with severe retinal toxicity, requiring a discontinuation of therapy. Nov 01, 2015 H ydroxychloroquine HCQ; Plaquenil, Sanofi, Bridgewater, NJ is an antimalarial agent that is also commonly used as a treatment for a variety of rheumatologic and dermatologic conditions, such as rheumatoid arthritis and systemic lupus erythematosus. The most common side effect associated with its use is retinal toxicity, which may be.